Guangzhou R&F Hospital Center of Excellence in Oncology is built to meet the standards of top cancer centers in both China and abroad. With Medpoint’s international hospital operations experience and with plans to collaborate with leading United States-based academic medical centers, we aim to establish an advanced cancer center that integrates standardized management and high-quality medical services, delivering a complete range of services from cancer prevention, screening, diagnosis, to treatment and recovery.
The CoE in Oncology has gathered an accomplished team featuring renowned experts from major cancer centers, including oncologists of various subspecialties and a highly experienced nursing group to jointly deliver high-quality care to patients. The Center adopts an evidence-based patient-centered philosophy to work in combination with our advanced equipment, high-end diagnosis and treatment techniques and a multidisciplinary model. Our team will work closely with top experts from United States-based academic medical centers to apply the most advanced diagnosis and treatment plans worldwide in combination with Chinese guidelines, delivering comprehensive and precise diagnosis and treatment for patients with hematologic or solid tumors.
Here you can enjoy a comfortable and private environment during diagnosis and treatment, warm and thoughtful nursing services, as well as comprehensive and individualized medical solutions of international quality. The medical services we provide include: international standardized cancer treatment, multi-disciplinary consultation with top experts from China and overseas, international two-way referral, accurate tumor screening, post-cancer rehabilitation, and full life-cycle health management.
Center of Excellence in Oncology
Chinese
Chinese, English
Prof. Jiang received his medical degree from Shanghai Medical University in 1982. Between 1997 and 2000, he was selected by the Ministry of Health and sent to M.D. Anderson Cancer Center and other famous cancer center in the U.S as a visiting scholar. In 2005, he received his h-EMBA degree from Sun Yat-Sen University. He has been engaged in clinical practice of solid tumors for over 30 years, and has rich clinical experience in MDT treatment of various types of tumors (including chemotherapy, endocrine therapy, biotherapy and immunotherapy, etc.). He won the "National Outstanding Scientific and Technological Worker) in 2014.
Prof. Jiang returned to China in 2000. He was hired to be chief physician of Internal Medicine Department, second level professor, PhD advisor and chief expert of Oncology Medicine at Sun Yat-Sen University Cancer Center. He served as Chief of Medicine, Chief of Lynphoma Center, Vice President of Cancer Center, and director of the Academic Committee of the National Anti-Cancer New Drug Clinical Trial Center. He also worked as first dean of Shenzhen University Medical School and CEO of its affiliated hospital, and president of Boao Evergrande International Hospital (Brigham and Women's Hospital). From 2021, he began to serve as Deputy CMO and Chair of CoE in Oncology at Guangzhou R&F Hospital.
Prof. Jiang is taking the following academic positions: Vice president of Oncology Branch of Chinese Medical Doctor Association, executive director and deputy secretary-general of China Anti-Cancer Association, vice chairman of Hong Kong and Macao Anti-Cancer Association, chairman of Clinical Chemotherapy Professional Committee of China Anti-Cancer Association Cancer, chairman of the Lymphoma Professional Committee of China Anti-Cancer Association, chairman of the Oncology Professional Committee of Guangdong Medical Association, deputy chairman of Oncology Branch of Guangdong Clinical Medical Association, chairman of the Oncology Specialty Alliance of South China Medical Association, etc. He is also an associate editor of "Journal of International Oncology" and "Chinese Journal of Clinical Oncology", editorial board member of "Lancet" and "Journal of Clinical Oncology" (Chinese edition).
Prof. Jiang has presided over the "New Anti-Cancer Drug Research Platform" project under the National Key Research Program. He is the editor-in-chief of several monographs such as "Clinical Oncology", "Lymphoma Diagnosis and Therapeutics" and "Oncology Biotherapy". He is a member of the clinical diagnosis and treatment expert team appointed by the Ministry of Health (Oncology). He has won honorary titles including "Famous Oncologist in China", "Sun Yat-Sen University Famous Doctor", "South China Famous Doctor" etc. He was member of the Standing Committee of Guangdong Provincial Committee of Chinese People’s Political Consultative Conference for two sessions.
